UZABASE USA, INC. – Trademark Portfolio
Entity Type: 03
UZABASE USA, INC. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 2 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 4 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include SPEEDA EDGE. The owner is based in NEW YORK, NY.
211 EAST 43RD ST.
NEW YORK, NY 10017
Showing of trademarks Trademarks
Trademark Classifications
UZABASE USA, INC.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Education; providing of training; entertainment; sporting and cultural activities
Insurance; financial affairs; monetary affairs; real estate affairs
Frequently Asked Questions
How many trademarks does UZABASE USA, INC. have?
UZABASE USA, INC. has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned.
What trademark classes does UZABASE USA, INC. file in?
UZABASE USA, INC. files trademarks across 4 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 42 (Computer & Scientific), Class 41 (Education & Entertainment), Class 36 (Insurance & Financial). Class 35 covers advertising; business management; business administration; office functions.
What are UZABASE USA, INC.'s most well-known trademarks?
UZABASE USA, INC.'s registered trademark portfolio includes well-known marks such as SPEEDA EDGE. These are among 1 currently registered trademark in the portfolio.
What is UZABASE USA, INC.'s trademark registration success rate?
UZABASE USA, INC. has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.